CymitQuimica logo

CAS 10080-05-4

:

Formule :C15H23N3O3S
InChI :InChI=1S/C15H23N3O3S/c16-22(20,21)14-8-6-12(7-9-14)10-11-17-15(19)18-13-4-2-1-3-5-13/h6-9,13H,1-5,10-11H2,(H2,16,20,21)(H2,17,18,19)
Code InChI :NIMGDPRCIUIRNT-UHFFFAOYSA-N
SMILES :C1CCC(CC1)NC(=O)NCCC2=CC=C(C=C2)S(=O)(=O)N
6 produits trouvés.
  • Glipizide EP Impurity H

    CAS :
    Formule :C15H23N3O3S
    Couleur et forme :White To Off-White Solid
    Masse moléculaire :325.43

    Ref: 4Z-G-115

    5mg
    À demander
    100mg
    À demander
    10mg
    436,00€
    25mg
    623,00€
    50mg
    810,00€
  • 4-[2-[(Cyclohexylcarbamoyl)amino]ethyl]benzenesulphonamide

    Produit contrôlé
    CAS :
    Formule :C15H23N3O3S
    Couleur et forme :Neat
    Masse moléculaire :325.43

    Ref: 86-MM0942.08

    25mg
    358,00€
    100mg
    1.500,00€
  • 4-(2-(3-Cyclohexylureido)ethyl)benzenesulfonamide

    CAS :
    Degré de pureté :97%
    Masse moléculaire :325.4299927

    Ref: 10-F728487

    250mg
    838,00€
    1g
    1.955,00€
  • 1-Cyclohexyl-3-(p-sulfamoylphenethyl)urea

    Produit contrôlé
    CAS :

    Impurity Glipizide EP Impurity H
    Applications 1-Cyclohexyl-3-(p-sulfamoylphenethyl)urea (Glipizide EP Impurity H) is an impurity of Glipizide (G410225).
    References Jurca, B. et al.: J. Therm. Anal. Calor., 62, 859 (2000);

    Formule :C15H23N3O3S
    Couleur et forme :Neat
    Masse moléculaire :325.43
  • Glipizide EP Impurity H

    CAS :
    Formule :C15H23N3O3S
    Masse moléculaire :325.43

    Ref: ST-EA-CP-G11008

    10mg
    À demander
    25mg
    À demander
    50mg
    À demander
    100mg
    À demander
  • 4-(2-((Cyclohexylcarbamoyl)amino)ethyl)benzenesulfonamide

    CAS :
    4-(2-((Cyclohexylcarbamoyl)amino)ethyl)benzenesulfonamide is a research and development impurity standard that is used for the synthesis of drug products. CAS No. 10080-05-4, 4-(2-((Cyclohexylcarbamoyl)amino)ethyl)benzenesulfonamide is a synthetic compound that has been shown to be metabolized in humans and in rats. It has been extensively evaluated as a potential antituberculosis drug candidate and shown to inhibit bacterial growth by binding to DNA-dependent RNA polymerase, thereby preventing transcription and replication. This active form is metabolized through a number of metabolic transformations, including hydrolysis by esterases or glucuronidases, oxidation by cytochrome P450 enzymes, reduction by glutathione reductase, or conjugation with glucuronic acid. In vitro studies have demonstrated its efficacy against Mycobacter
    Formule :C15H23N3O3S
    Degré de pureté :Min. 95%
    Masse moléculaire :325.4 g/mol